| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP &Chief Operating Officer | SVP &Chief Financial Officer
1 company
Nicholson John is a SVP &Chief Operating Officer at NEKTAR THERAPEUTICS. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $10.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2017 | NKTR Nektar Therapeutics | SVP &Chief Operating Officer | Sale+OE | 101,700 | $19.24 | $1,956,708.00 | -30.9% | |
| May 16, 2017 | NKTR Nektar Therapeutics | SVP &Chief Operating Officer | Sell | 3,146 | $19.55 | $61,504.30 | -1.7% | |
| Feb 16, 2017 | NKTR Nektar Therapeutics | SVP &Chief Operating Officer | Sell | 3,237 | $13.14 | $42,534.18 | -1.7% | |
| Feb 3, 2017 | NKTR Nektar Therapeutics | SVP &Chief Operating Officer | Sale+OE | 75,000 | $12.39 | $929,350.50 | -21.1% | |
| Nov 16, 2016 | NKTR Nektar Therapeutics | SVP &Chief Operating Officer | Sell | 1,654 | $13.96 | $23,089.84 | -1.4% | |
| Aug 16, 2016 | NKTR Nektar Therapeutics | SVP &Chief Operating Officer | Sell | 3,317 | $17.56 | $58,246.52 | -2.6% | |
| May 17, 2016 | NKTR Nektar Therapeutics | SVP &Chief Financial Officer | Sale+OE | 856 | $13.58 | $11,624.48 | -1.1% | |
| Feb 17, 2016 | NKTR Nektar Therapeutics | SVP &Chief Financial Officer | Sale+OE | 963 | $11.92 | $11,478.96 | -1.2% | |
| Aug 12, 2015 | NKTR Nektar Therapeutics | SVP &Chief Financial Officer | Sale+OE | 319,884 | $10.78 | $3,449,413.56 | -67.9% |